Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea

Journal of the College of Physicians and Surgeons Pakistan

Volumn 22, Issue 12, 2012, Pages 751-755

  Shaikh, Kaleemullah ^a   Hanif, Bashir ^a   Siddique, Ali Akber ^b   Yousuf Shaikh, M ^a   Noman Khan, M ^a  

^a Tabba Heart Institute   (Pakistan)

^b ISRA UNIVERSITY   (Pakistan)

Author keywords

Congestive heart failure; Dyspnoea echocardiography; Ejection fraction; Left ventricular dimension; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

EID: 84871852579     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nielsen LS, Svanegaard J, Wiggers P, Egeblad H. The yield of a diagnostic hospital dyspnoea clinic for the primary health care section. J Intern Med 2001; 250: 422-8.
2. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596-602.
3. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: findings from the resource utilization among congestive heart failure (REACH) study. J Am Coll Cardiol 2002; 39: 60-9.
4. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
5. Redfield MM, Aarhus LL, Wright RS, Burnett JC Jr. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation 1993; 87: 2016-22.
6. Lainchbury JG, Espiner EA, Nicholls MG. Richards AM. Cardiac hormones: diagnosis and therapeutical potential. NZ Med J 1997; 110: 219-21.
7. Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cleland JG, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008; 10: 824-39. Epub 2008 Aug 29.
8. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007; 137: 4-12.
9. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, et al. BNP-guided vs. symptom-guided heart failure therapy: the trial of intensified vs. standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial. JAMA 2009; 301: 383-92.
10. de Filippi CR, Christenson RH, Gottdiener JS, Kop WJ, Seliger SL. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. J Am Coll Cardiol 2010; 55: 441-50.
11. Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, et al. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-assisted treatment to lessen serial cardiac readmissions and death) trial. J Am Coll Cardiol 2009; 55: 53-60.
12. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004; 43: 416-22.
13. Kelly R, Struthers AD. Are natriuretic peptides clinically useful as markers of heart failure? Ann Clin Biochem 2001; 38: 94-102.
14. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal pro-BNP investigation of dyspnoea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95: 948-54.
15. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 2003; 89: 150-4.
16. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004; 43: 416-22.
17. Yap LB. B-type natriuretic peptide and the right heart. Heart Fail Rev 2004; 9: 99-105.
18. Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004; 94: 740-5.
19. Logeart D, Saudubray C, Beyne P, Thabut G, Ennezat PV, Chavelas C, et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnoea. J Am Coll Cardiol 2002; 40: 1794-800.
20. Kotaska K, Popelova J, Tiserova M, Telekes P, Vrzanova M, Bronsky J, et al. NT-proBNP and BNP values in cardiac patients with different degree of left ventricular systolic dysfunction. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006; 150: 125-30.
21. Turley AJ, Roberts AP, Davies A, Rowell N, Drury J, Smith RH, et al. NT-proBNP and the diagnosis of left ventricular systolic dysfunction within two acute NHS trust catchment areas: the initial Teesside experience. Postgrad Med J 2007; 83: 206-8.
22. Gustafsson F, Badskjaer J, Hansen FS, Poulsen AH, Hildebrant P. Value of N-terminal proBNP in the diagnosis of left ventricular systolic dysfunction in primary care patients referred for echocardiography. Heart Drug 2003; 3: 141-6.
23. Mele D, Teoli R, Cittanti C, Pasanisi G, Guardigli G, Levine RA, et al. Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders. Int J Cardiovasc Imaging 2004; 20: 191-202.